术中流式细胞术超快速评估脑膜瘤恶性程度
本研究在手术中对117例脑膜瘤行术中流式细胞术(iFC),以DNA含量高于正常的细胞比例计算恶性指数(MI),并与2016年WHO分级比较。iFC自动测量平均约9分钟;WHO I级与II/III级脑膜瘤间MI差异有统计学意义(P<0.001)。以MI 8.0%为界区分I级与II/III级,敏感度64.7%、特异度85.0%。
要点
- iFC自动测量MI平均约需9分钟,可在术中获得结果
- WHO I级与II/III级脑膜瘤MI差异有统计学意义(P<0.001)
- 区分I级与II/III级的最佳MI界值为8.0%,敏感度64.7%、特异度85.0%
核心结论
- 作者认为,用iFC计算MI在技术上可行且可靠,可用于脑膜瘤恶性程度的超快速评估。
- 作者认为,iFC测得的MI可能有助于在手术中确定最佳治疗策略,如肿瘤切除范围及受累正常脑或神经的处理。
研究设计与样本
- 本研究为术中iFC评估脑膜瘤恶性程度的研究,共分析117例脑膜瘤。
- 每例计算恶性指数(MI),即DNA含量高于正常的细胞数占总细胞数的比例。
- 每份标本均行组织病理学检查,并按2016年WHO分级系统进行诊断分级。
- 将MI结果与脑膜瘤的WHO分级进行比较。
主要发现
- iFC自动测量平均约需9分钟。
- WHO I级与II/III级脑膜瘤之间的MI差异有统计学意义(P<0.001)。
- 受试者工作特征分析得出区分I级与II/III级的最佳MI界值为8.0%。
- 以MI 8.0%为界,对II/III级脑膜瘤的敏感度为64.7%、特异度为85.0%。
关键数值与推荐
- 区分WHO I级与II/III级脑膜瘤的最佳MI界值为8.0%。
- 以MI 8.0%为界,II/III级脑膜瘤的敏感度为64.7%、特异度为85.0%。
临床怎么用
- 作者认为,iFC测得的MI可能有助于在手术中确定最佳治疗策略,如肿瘤切除范围及受累正常脑或神经的处理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognosis for World Health Organization (WHO) grade II/III meningiomas is worse than for WHO grade I meningiomas. Histopathologic grade should ideally be identified during tumor resection, but current methods are time-consuming and have doubtful reliance. The aim of this study was to evaluate intraoperative flow cytometry (iFC) as a method for providing ultrarapid evaluation of meningioma malignancy. METHODS: A total of 117 meningiomas were analyzed with iFC during surgery. For each, the malignancy index (MI) was calculated as the number of cells with a greater than normal DNA content as a proportion of the total number of cells. Each specimen was investigated histopathologically and was diagnostically graded according to the 2016 WHO grading system. MI results were compared with WHO grades of the meningiomas. RESULTS: The automatic measurement of iFC took approximately 9 minutes on average. The difference in MI between grade I and grade II/III meningiomas was statistically significant (P < 0.001). Receiver operating characteristic analysis provided an optimal cutoff MI value of 8.0% for discrimination between grade I and grade II/III groups, with 64.7% sensitivity and 85.0% specificity for grade II/III meningiomas. CONCLUSIONS: Our method of calculating MI with iFC appears to be technically feasible and reliable for ultrarapid evaluation of meningioma malignancy. MI with iFC could potentially enable determination of an optimal treatment strategy during surgery, such as extent of resection of the tumor and management of invaded normal brain or nerves.
引用
- Matsuoka G, Eguchi S, Anami H, et al. Ultrarapid Evaluation of Meningioma Malignancy by Intraoperative Flow Cytometry. World Neurosurg. 2018. PMID: 30144616. doi:10.1016/j.wneu.2018.08.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。